Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Associated Lipodystrophy Syndrome.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT03226821
What this trial is testing

Body Composition and Adipose Tissue in HIV

Who this might be right for
HIV Lipodystrophy SyndromeGrowth Hormone DeficiencyBody Composition
Columbia University 6
Post-approval studies (Phase 4)Study completedNCT00646984
What this trial is testing

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Hospital Clinic of Barcelona 147
Early research (Phase 1)Study completedNCT02342223
What this trial is testing

Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy

Who this might be right for
HIV Facial Lipoatrophy
Jared Jagdeo, MD, MS 20
Testing effectiveness (Phase 2)Study completedNCT00461552
What this trial is testing

Therapeutic Approaches to HAART-Induced Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
University of Texas Southwestern Medical Center 23
Not applicableStudy completedNCT02530827
What this trial is testing

Energy Expenditure of People Living With HIV/AIDS

Who this might be right for
HIV/AIDSHIV Lipodystrophy Syndrome
University of Sao Paulo General Hospital 45
Post-approval studies (Phase 4)Study completedNCT04340388
What this trial is testing

Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Who this might be right for
HIV-1-infectionAntiviral Drug Adverse ReactionVascular Diseases+5 more
Augusta University 10
Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Post-approval studies (Phase 4)Study completedNCT00135356
What this trial is testing

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Bristol-Myers Squibb 219
Not applicableStudy completedNCT01359917
What this trial is testing

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
NHS Lothian 50
Large-scale testing (Phase 3)Study completedNCT00123253
What this trial is testing

TH9507 in Patients With HIV-Associated Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
Theratechnologies 412
Post-approval studies (Phase 4)Study completedNCT00139178
What this trial is testing

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Who this might be right for
HIV Associated Lipodystrophy Syndrome.HIVHypercholesterolemia+1 more
Danish HIV Research Group 100
Large-scale testing (Phase 3)Study completedNCT00608023
What this trial is testing

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Who this might be right for
LipodystrophyHIV Infections
Theratechnologies 263